Romosozumab
Approved, for something elseMeasured in people, not heightBy injectionAntibodyAlso Evenity
An injected antibody for thinning bones in older women, which removes one of the body's own brakes on bone building.
Monoclonal antibody neutralising sclerostin, freeing LRP5/6. Approved in 2019 for postmenopausal osteoporosis at high fracture risk.
Risks. It carries the strongest kind of label warning there is, for heart attack, stroke and death from heart disease.
On this page
- At the growth plate, members only
- Risks and side effects, members only
The rest of this page is for members
What has been measured, in whom, with every source, and what it does to the rest of you. And every article in the library.
Join for $11.99Lifetime · 3 of 10 founding spots left
Tax is added at checkout (VAT/GST where it applies).
Renews every month at the current price plus tax until you cancel. Cancel from your account before the next monthly charge to stop it.
Card purchases are sold and charged by Link (Stripe) under Link's terms and refund policy.
Already a member? Sign in
Educational content, not medical advice. Nothing here is a recommendation to take or stop taking anything — talk to a doctor about your own situation.